Poland· PL-100543170
Etcamah
A medicinal product containing camizestrant, registered in Poland by AstraZeneca AB.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Camizestrant
- Manufacturer
- AstraZeneca AB
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05000456097642
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Camizestrant in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEtcamah 75 mgAstraZeneca
- CzechiaETCAMAHAstraZeneca AB, Södertälje
- FinlandETCAMAHAstraZeneca AB
- SwedenEtcamah 75 mg Filmdragerad tablettAstraZeneca AB
- United StatesETCAMAHAstraZeneca Pharmaceuticals LP
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Etcamah
- Liechtenstein · Etcamah
- Norway · Etcamah
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9189a2fe-7785-4315-9e40-81b6ca3107a0 GET /v1/drugs/9189a2fe-7785-4315-9e40-81b6ca3107a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "75 mg",
"packaging": "05000456097642 ¦ Rpz ¦ EU/1/26/2046/001 ¦ 168104\n28 tabl.",
"substance": "Kamizestrant/75 mg",
"common_name": "Camizestrant",
"pl_product_id": "100543170",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about camizestrant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.